Anthropic Secondary Market Heats Up Amid Fraud Concerns Global Markets Dip as Middle East Tensions Fuel Oil Price Surge US Growth Revised Downward SGX RegCo Proposes ThreeYear Deadline for Suspended Firms to Resume Trading or Face Delisting Retail Sales Defy Consumer Pessimism How Long Can the Paradox Last Indian Commerce Department Gathers Industry Input on NonTariff Barriers Ahead of US Trade Team Visit Pokmon Card Market Boom Nostalgia Speculation and Celebrity Involvement Drive HighValue Sales United Community Banks Inc UCB Q1 2026 Earnings Earnings Miss Expectations Despite Solid Profitability VNT Q1 2026 Earnings EPS Falls Short of Estimates Shares Slip RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts Airgain Inc AIRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction PEW Q1 2026 Earnings EPS Beat Drives Optimism Despite Revenue Uncertainty and Stock Dip FGBIP Preferred Stock Holds Steady at 2049 as Yield Attracts Income Seekers Cheniere Energy Partners CQP Holds Steady Near 61 Showing Resilience in Quiet Trading Atlanticus Holdings Senior Notes ATLCL Hold Steady at 2515 Amidst Stable Yield Considerations AEye Inc LIDR Gains 37 as Shares Approach Key Resistance BankUnited BKU Gains 214 Regional Bank Strength Tests Key Resistance Zone US Productivity Growth Moderates in Q4 as Labor Costs Rise Implications for Inflation and Fed Policy CATO Q4 2025 Earnings Reported Loss of 055 Per Share Shares Decline 64 Moolec Science MLEC Slides 44 Amid Selling Pressure Key Support at 706 in Focus Cinemark Holdings CNK Posts Modest Gain as Stock Approaches Key Resistance Compugen Surges 7 as Biotech Stock Tests Key Resistance Levels CGEN Cohen Steers LDP Holds Steady Near Support Amid Preferred Income Stability High Roller Technologies ROLR Slips 236 as Stock Tests Key Support Near 512 LPL Financial Holdings LPLA Slides 48 as Broader Market Pressure Weighs on Financials Precision Drilling PDS Drops 324 as Weakness Tests Support at 8524 Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance